What if doctors could look at a person’s DNA and not only spot a harmful mutation, but also predict the kind of disease it ...

Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced that Gijs van den Brink, MD, PhD, has been ...

JPMorgan Equity Premium Income ETF delivers consistent monthly income with a 7-8% yield, though it lags the broader market's ...

Investigations suggest V2P may be efficiently applied for the automated identification of causal variants in simulated and actual patient sequencing data across phenotypes.

Say you want to listen in on a group of super-intelligent aliens whose language you don't understand, and whose spaceship ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Mycelium materials can grow from agricultural and food waste, forming foams, panels, and textiles that challenge plastics in ...

The rapid expansion of high-throughput sequencing technologies has generated unprecedented amounts of multi-omics data, ...

Promising data show a median overall survival of 18.6 months, with 40% of patients alive at 2 years.Results suggest that nuclear GSK-3β ...

The combination was well tolerated: no treatment-related deaths occurred, and only 6% (2 patients) were discontinued due to ...

Cherry leaf spot is a destructive disease that causes premature defoliation, fruit yield loss, and long-term tree weakening in cherry orchards.

Rona Therapeutics, a clinical-stage RNAi company, today announced the recent completion of Cohort 1 dosing in its Phase 1 first-in-human clinical study of RN3161, an investigational GalNAc-conjugated ...